The document outlines a government solicitation for the development of a non-destructive viral identification technology under the HR0011SB20254-01 request. The objective is to create a portable, low power, and lightweight system that can identify viruses in the field without compromising sample viability. Current identification methods often destroy samples, limiting further analysis. The project seeks to leverage advances in technology such as microfluidics, high-resolution imaging, and metasurfaces. Phase I invites Direct to Phase II proposals, requiring candidates to demonstrate the ability to identify various viruses rapidly and provide a pathway toward a scalable portable system. In Phase II (24 months), developers will enhance the system’s accuracy, diversity of viral detection, and sample handling, with multiple demonstrations planned throughout the development process. Successful technology could have significant implications for both defense and commercial industries, facilitating rapid on-site pathogen identification and enhancing biological surveillance capabilities. The document specifies milestone metrics for both phases, emphasizing sensitivity and speed, indicating the Defense Department’s commitment to improving biodefense capabilities.